KI, OUH, Forskningsenhed for Klinisk Immunologi (Odense)

Medicin og biovidenskab

1. Alleles 15%
2. Anti-Citrullinated Protein Antibodies 10%
3. anti-IgG 10%
4. Antibodies 53%
5. Antibody Formation 18%
6. Antibody-Producing Cells 26%
7. Antigens 14%
8. Aquaporin 4 16%
9. Autoantibodies 14%
10. B-Lymphocytes 26%
11. Biomarkers 20%
12. Biopsy 11%
13. Blood Donors 100%
14. Blood Group Antigens 26%
15. Blood Platelets 15%
16. Blood Safety 13%
17. Blood Transfusion 25%
18. Celiac Disease 38%
19. Cerebrospinal Fluid 13%
20. Child 25%
21. Chimeric Antigen Receptors 19%
22. Chimerism 17%
23. Chronic Hepatitis C 10%
24. Cohort Studies 44%
25. Confidence Intervals 21%
26. Conjugate Vaccines 22%
27. Coronavirus 31%
28. Coronavirus Infections 13%
29. Cross-Sectional Studies 15%
30. Denmark 93%
31. Diphtheria Toxoid 9%
32. Encephalitis 11%
33. Enzyme-Linked Immunosorbent Assay 14%
34. Epidemiology 12%
35. Erythema Infectiosum 10%
36. Erythrocytes 15%
37. Exons 10%
38. Familial Mediterranean Fever 10%
39. Fecal Microbiota Transplantation 16%
40. Genes 23%
41. Haemophilus influenzae type b 36%
42. Hemorrhage 11%
43. Hepacivirus 12%
44. Hepatitis B 16%
45. Hepatitis C 13%
46. Hepatitis E 9%
47. Hereditary Angioedemas 9%
48. Hidradenitis Suppurativa 10%
49. HLA Antigens 10%
50. HLA-A Antigens 10%
51. Human Parvovirus B19 11%
52. Immunoglobulin A 22%
53. Immunoglobulin G 43%
54. Immunoglobulin M 20%
55. In Vitro Techniques 11%
56. Incidence 14%
57. Infections 30%
58. Iron 14%
59. Messenger RNA 11%
60. Meta-Analysis 10%
61. microfibrillar protein 20%
62. Mortality 10%
63. Mothers 13%
64. Multiple Myeloma 13%
65. Multiple Sclerosis 20%
66. Mutation 16%
67. Neoplasms 10%
68. Neuromyelitis Optica 35%
69. Odds Ratio 11%
70. Optic Neuritis 23%
71. Pandemics 15%
72. Parvovirus 12%
73. Phenotype 12%
74. Platelet Aggregation 13%
75. Polysaccharides 26%
76. Population 33%
77. Pregnancy 14%
78. Pregnant Women 13%
79. Prospective Studies 15%
80. Randomized Controlled Trials 10%
81. Registries 13%
82. Rheumatoid Arthritis 26%
83. RHO(D) antibody 11%
84. SARS Virus 59%
85. Seroepidemiologic Studies 16%
86. Serum 16%
87. Severe Acute Respiratory Syndrome 29%
88. Stem Cells 10%
89. Sweden 10%
90. Systematic Reviews 10%
91. T-Lymphocytes 36%
92. Tetanus Toxoid 12%
93. Therapeutics 17%
94. Tissue Donors 33%
95. Transplants 10%
96. Twin Studies 17%
97. Twins 11%
98. Vaccination 30%
99. Vaccines 21%
100. Virus Diseases 13%